Netripples Software Ltd
₹ 5.51
0.00%
24 Jul 2023
About
Incorporated in 1993, Netripples Software Ltd provides Healthcare and Education Informatics[1]
Key Points
- Market Cap ₹ 3.76 Cr.
- Current Price ₹ 5.51
- High / Low ₹ /
- Stock P/E 25.1
- Book Value ₹ 14.6
- Dividend Yield 0.00 %
- ROCE 0.30 %
- ROE 0.20 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.38 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -14.8% over past five years.
- Promoter holding is low: 35.5%
- Company has a low return on equity of 0.17% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Upcoming result date: 5 November 2025
Profit & Loss
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.26 | 13.27 | 15.88 | 22.81 | 25.67 | 24.99 | 14.00 | 10.91 | 9.29 | 4.80 | 3.93 | 6.27 | 6.51 | |
| 11.20 | 12.33 | 14.88 | 21.51 | 24.47 | 24.05 | 13.91 | 10.81 | 9.20 | 4.74 | 3.87 | 6.20 | 6.28 | |
| Operating Profit | 0.06 | 0.94 | 1.00 | 1.30 | 1.20 | 0.94 | 0.09 | 0.10 | 0.09 | 0.06 | 0.06 | 0.07 | 0.23 |
| OPM % | 0.53% | 7.08% | 6.30% | 5.70% | 4.67% | 3.76% | 0.64% | 0.92% | 0.97% | 1.25% | 1.53% | 1.12% | 3.53% |
| 0.28 | 0.00 | 0.00 | -0.28 | -0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.26 | 0.23 | 0.28 | 0.49 | 0.45 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.05 | 0.09 | 0.34 | 0.24 | 0.26 | 0.28 | 0.07 | 0.09 | 0.08 | 0.05 | 0.04 | 0.04 | 0.08 |
| Profit before tax | 0.03 | 0.62 | 0.38 | 0.29 | 0.42 | 0.47 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.15 |
| Tax % | 33.33% | 1.61% | 2.63% | 0.00% | 7.14% | 6.38% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| 0.02 | 0.61 | 0.38 | 0.28 | 0.39 | 0.44 | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 | 0.02 | 0.15 | |
| EPS in Rs | 0.03 | 0.89 | 0.56 | 0.41 | 0.57 | 0.65 | 0.01 | 0.01 | 0.00 | 0.01 | 0.03 | 0.03 | 0.22 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -15% |
| 3 Years: | -12% |
| TTM: | 61% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -26% |
| 5 Years: | 15% |
| 3 Years: | % |
| TTM: | 25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | -6% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 0% |
| 3 Years: | 0% |
| Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 |
| Reserves | 0.55 | 1.16 | 1.55 | 2.20 | 2.59 | 3.03 | 3.04 | 3.05 | 3.05 | 3.06 | 3.08 | 3.10 |
| 1.58 | 1.57 | 2.52 | 3.83 | 2.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.29 | 0.30 | 0.31 | 0.31 | 0.45 | 0.42 | 0.31 | 0.30 | 0.30 | 0.26 | 0.25 | 0.29 | |
| Total Liabilities | 9.24 | 9.85 | 11.20 | 13.16 | 12.73 | 10.27 | 10.17 | 10.17 | 10.17 | 10.14 | 10.15 | 10.21 |
| 0.24 | 0.40 | 0.50 | 0.28 | 0.31 | 0.20 | 0.64 | 0.54 | 0.42 | 0.20 | 0.13 | 0.13 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 9.00 | 9.45 | 10.70 | 12.88 | 12.42 | 10.07 | 9.53 | 9.63 | 9.75 | 9.94 | 10.02 | 10.08 | |
| Total Assets | 9.24 | 9.85 | 11.20 | 13.16 | 12.73 | 10.27 | 10.17 | 10.17 | 10.17 | 10.14 | 10.15 | 10.21 |
Cash Flows
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.69 | 1.64 | 3.48 | 0.00 | 0.00 | 0.00 | -0.04 | 0.08 | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Cash Flow | 0.00 | 0.00 | 0.69 | 1.64 | 3.48 | 0.00 | 0.00 | 0.00 | -0.05 | 0.08 |
Ratios
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 14.59 | 14.30 | 24.59 | 26.08 | 16.35 | 15.48 | 15.38 | 13.72 | 11.79 | 20.53 | 21.36 | 11.06 |
| Inventory Days | 4,150.71 | |||||||||||
| Days Payable | 32.76 | |||||||||||
| Cash Conversion Cycle | 14.59 | 14.30 | 24.59 | 26.08 | 16.35 | 15.48 | 4,133.33 | 13.72 | 11.79 | 20.53 | 21.36 | 11.06 |
| Working Capital Days | 268.73 | 240.95 | 230.54 | 135.05 | 125.27 | 139.34 | 246.11 | 319.84 | 380.32 | 753.57 | 929.68 | 580.39 |
| ROCE % | 9.19% | 6.46% | 7.48% | 5.96% | 0.20% | 0.10% | 0.10% | 0.10% | 0.20% | 0.30% |
Documents
Announcements
-
SQ2024 Cash Flow Updated In Financial Results As Per Matching XBRL As Trigerred
22 Oct - Q1 FY2024-25 standalone: revenue ₹166.98 lakh, net profit ₹6.83 lakh; Board approved results on 21 Oct 2024.
-
Cashflow Updated For MQ2025 As Triggered
21 Oct - Audited cash flow statement for year ended 31-Mar-2025 showing net cash increase 8.77.
-
Closure of Trading Window
21 Oct - Trading window closed 29 Oct–6 Nov 2025; board meeting for Q1 results on 5 Nov 2025.
-
Board Meeting Intimation for Unaudited Financial Results For Second Quarter
21 Oct - Board meeting rescheduled to 05-11-2025 11:00 to approve Q2 FY2025-26 unaudited results.
-
Disclosure under Regulation 30A of LODR
15 Oct - Company reports nil related party transactions for quarter ended 30 Sep 2025; filed under Reg 23(9).
Products & Services:[1]
Company's products and services are used in 20+ countries, 10 ministries of health and 3000+ Clients worldwide. It has 75 products and services in Healthcare Informatics and has the Only Store in the world which has the DIOMS (Downloadable, Instantaneous Installations, Operate, Maintenance and Services and Support Online). These include:
a) Ready to use Healthcare Informatics products
b) Consulting on Blood Bank and Blood Bank Networking and Standard Operating procedures
c) Outsourcing on Healthcare and Education and Supply Chain Software Development, Maintenance and Support
d) Project Migration from Client Server Technologies to Web based Technologies,
Mobile Technologies, and Cloud based Environment Deployment services
e) Data Migration, Data Storage, Data Center Management and Infrastructure Services
f) Online and E-commerce Store Setup, Establishment, and Training and Deployments
g) Franchise Establishment and Channel network support and services for the Netripples Products and Services